The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Open Life Sciences
(Jul 2023)
Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
Ruan Zijing,
Tang Jiaxi,
Zeng Mingtang,
Fan Ping
Affiliations
Ruan Zijing
Department of Clinical Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China
Tang Jiaxi
Department of Clinical Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China
Zeng Mingtang
Department of Clinical Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China
Fan Ping
Department of Clinical Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China
DOI
https://doi.org/10.1515/biol-2022-0637
Journal volume & issue
Vol. 18, no. 1
pp. e2449 – 20
Abstract
Read online
No abstracts available.
Keywords
sars-cov-2
virtual screening
potential inhibitor
cd13
pikfyve
drug repurposing
WeChat QR code
Close
